These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33972235)

  • 21. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S; Balcı Ö; Tanyıldız B; Kebudi R; Shields CL
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
    Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
    J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOXICITY AND EFFICACY OF INTRAVITREAL MELPHALAN FOR RETINOBLASTOMA: 25 µg Versus 30 µg.
    Liao A; Hsieh T; Francis JH; Lavery JA; Mauguen A; Brodie SE; Abramson DH
    Retina; 2021 Jan; 41(1):208-212. PubMed ID: 32106160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
    Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological findings in enucleated eyes after intravitreal melphalan injection.
    Ghassemi F; Amoli FA
    Int Ophthalmol; 2014 Jun; 34(3):533-40. PubMed ID: 24043335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
    Ophthalmology; 2024 Oct; 131(10):1215-1224. PubMed ID: 38703794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoblastoma Vitreous Seed Clouds (Class 3): A Comparison of Treatment with Ophthalmic Artery Chemosurgery with or without Intravitreous and Periocular Chemotherapy.
    Francis JH; Iyer S; Gobin YP; Brodie SE; Abramson DH
    Ophthalmology; 2017 Oct; 124(10):1548-1555. PubMed ID: 28545735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding.
    Koç İ; Taylan Şekeroğlu H; Kıratlı H; Lotfisadigh S
    Eur J Ophthalmol; 2022 May; 32(3):1766-1771. PubMed ID: 34082595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL
    Arch Ophthalmol; 2012 Oct; 130(10):1268-71. PubMed ID: 23044940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
    Francis JH; Marr BP; Brodie SE; Gobin YP; Abramson DH
    JAMA Ophthalmol; 2014 Aug; 132(8):1024-5. PubMed ID: 25124953
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal chemotherapy provides control for massive vitreous seeding from retinoblastoma.
    Lawson BM; Saktanasate J; Say EA; Shields CL
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e92-4. PubMed ID: 25490242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low retinal toxicity of intravitreal carboplatin associated with good retinal tumour control in transgenic murine retinoblastoma.
    Lemaître S; Poyer F; Fréneaux P; Leboucher S; Doz F; Cassoux N; Thomas CD
    Clin Exp Ophthalmol; 2020 May; 48(4):500-511. PubMed ID: 31872542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-term efficacy of intravitreal injection of melphalan for refractory vitreous seeding from retinoblastoma].
    Xue K; Ren H; Zhang R; Yuan YF; Qian J
    Zhonghua Yan Ke Za Zhi; 2017 Aug; 53(8):570-574. PubMed ID: 28851196
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravitreal injection of melphalan in the treatment of retinoblastoma with vitreous cavity seeding.
    Sun YB; Hui P; Punyara K; Bi MC; Li SH; Teng SY; Song E
    Chin Med J (Engl); 2013; 126(8):1587. PubMed ID: 23595400
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistence of retinal function after intravitreal melphalan injection for retinoblastoma.
    Brodie SE; Munier FL; Francis JH; Marr B; Gobin YP; Abramson DH
    Doc Ophthalmol; 2013 Feb; 126(1):79-84. PubMed ID: 23143758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding.
    Cieślik K; Rogowska A; Danowska M; Hautz W
    Adv Clin Exp Med; 2024 Feb; 33(2):119-125. PubMed ID: 37260052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
    Solana-Altabella A; Valero S; Balaguer J; Escobar-Cava P; Barranco H; López E; Ribes-Artero H; Poveda JL
    J Oncol Pharm Pract; 2020 Dec; 26(8):1829-1835. PubMed ID: 32063104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.